The Brigham Board Review in Oncology 2016 - Videos + PDF

The Brigham Board Review in Oncology 2016 – Videos + PDF

Login is required

login

If you are not our user, for invitation Click Here

OakStone price $1395

Date of Original Release: June 30, 2016
Termination Date: June 30, 2019

File Size : 6.95Gb

Brigham and Women’s Hospital and Oakstone Board Review

Prepare for your medical oncology board exam with this in-depth CME program. Ideal for MOC.

Earn CME Credit with this Comprehensive Board Review in Oncology

The Brigham Board Review in Oncology is a CME course designed to update knowledge and improve management strategies. Case-based presentations from a distinguished faculty of experts will enhance patient care while you prep for the board exam by learning to:

  • Apply recommended Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex Oncologic disorders
  • Identify and apply current therapeutic options for Oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to Oncology

Discover New Guidelines

A clinically based update, this learn-at-your-own-pace course in Oncology provides a maximum of 31.25 AMA PRA Category 1 Credits and 31.25 MOC points. Available online or on disk, it provides access to unbiased, evidence-based content and case-based reviews so that you may expand your knowledge and incorporate the latest guidelines into your daily practice.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

  • Molecular Genetics of Cancer – Levi A. Garraway, MD, PhD
  • Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients – Joel T. Katz, MD
  • Symptom Management in Patients with Cancer – Janet L. Abrahm, MD
  • Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD
  • Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
  • Acute Leukemias – Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome – David P. Steensma, MD
  • Chronic Myelogenous Leukemia – Joseph H. Antin. MD
  • Myeloproliferative Syndromes – Ann M. Mullally, MD
  • Multiple Myeloma – Kenneth C. Anderson, MD
  • Waldenstrom’s Macroglobulemia, Amyloidosis – Irene M. Ghobrial, MD
  • Low Grade Lymphomas – Caron A. Jacobson, MD
  • High Grade Lymphomas – Arnold S. Freedman, MD
  • Hodgkin’s Lymphoma – George P. Canellos, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
  • Head and Neck Cancer – Robert I. Haddad, MD
  • Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer – Mark Awad, MD
  • Mesothelioma and Thymoma – Geoffrey R. Oxnard, MD
  • Thyroid Cancer – Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors – Matthew H. Kulke, MD
  • Esophageal and Gastric Cancer – Charles S. Fuchs, MD, MPH
  • Pancreatic and Hepatobilary Cancer – Brian M. Wolpin, MD
  • Anal Cancers – Robert J. Mayer, MD
  • Colorectal Cancers – Robert J. Mayer, MD
  • Gastrointestinal Cancer- Genetic Syndromes – Matthew Yurgelun, MD
  • Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Christopher J. Sweeney, MBBS
  • Renal and Bladder Cancer – Toni K. Choueiri, MD
  • Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD
  • Melanoma – F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD
  • Ovarian Cancer – Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology – David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH
  • Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD
  • Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD
  • Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

Post Comment